My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 816

    1.

    Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

    Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.

    Ann Intern Med. 2001 Oct 2;135(7):493-501.PMID: 11578152 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

    JAMA. 1998 Aug 19;280(7):605-13.PMID: 9718051 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):58-66.PMID: 12090863 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

    JAMA. 2000 Apr 12;283(14):1845-52.PMID: 10770146 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.

    Nevitt MC, Felson DT, Williams EN, Grady D.

    Arthritis Rheum. 2001 Apr;44(4):811-8.PMID: 11315920 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

    Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

    Ann Intern Med. 2000 May 2;132(9):689-96.PMID: 10787361 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS).

    Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB.

    Circulation. 2001 Feb 6;103(5):638-42.PMID: 11156873 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of estrogen therapy on gallbladder disease.

    Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.

    JAMA. 2005 Jan 19;293(3):330-9.PMID: 15657326 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

    Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB.

    Control Clin Trials. 1998 Aug;19(4):314-35.PMID: 9683309 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

    JAMA. 2002 Jul 17;288(3):321-33.PMID: 12117397 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Estrogen plus progestin and the risk of coronary heart disease.

    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M; Women's Health Initiative Investigators.

    N Engl J Med. 2003 Aug 7;349(6):523-34.PMID: 12904517 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

    JAMA. 2003 Oct 1;290(13):1729-38.PMID: 14519707 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hormone replacement therapy in postmenopausal women with heart disease and risk for gallstones that require surgery.

    [No authors listed]

    Ann Intern Med. 2001 Oct 2;135(7):S-44. No abstract available. PMID: 11596574 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

    [No authors listed]

    JAMA. 1996 Feb 7;275(5):370-5.PMID: 8569016 [PubMed - indexed for MEDLINE]Related articles

    19.

    Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

    JAMA. 2004 Jun 23;291(24):2947-58.PMID: 15213206 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

    Ann Intern Med. 2003 Jan 7;138(1):1-9.PMID: 12513038 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity